Tango Therapeutics (TNGX) Short Interest Ratio & Short Volume → After Conviction, More Bad News for Trump (From Paradigm Press) (Ad) Free TNGX Stock Alerts $6.90 -0.30 (-4.17%) (As of 06/7/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Tango Therapeutics Short Interest DataCurrent Short Interest10,620,000 sharesPrevious Short Interest10,890,000 sharesChange Vs. Previous Month-2.48%Dollar Volume Sold Short$82.84 millionShort Interest Ratio17.9 Days to CoverLast Record DateMay 15, 2024Outstanding Shares106,850,000 sharesFloat Size88,030,000 sharesShort Percent of Float12.06%Today's Trading Volume741,147 sharesAverage Trading Volume518,396 sharesToday's Volume Vs. Average143% Short Selling Tango Therapeutics ? Sign up to receive the latest short interest report for Tango Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartTNGX Short Interest Over TimeTNGX Days to Cover Over TimeTNGX Percentage of Float Shorted Over Time Ad Paradigm PressAfter Conviction, More Bad News for TrumpAs a former advisor to the CIA, the Pentagon and the White House… I feel it’s my duty to warn you about this coming election meltdown.Click here to see the details because this coming election meltdown could trigger… Tango Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 5/15/202410,620,000 shares $82.84 million -2.5%12.1%17.9 $7.80 4/30/202410,890,000 shares $83.85 million +2.5%19.8%17.7 $7.70 4/15/202410,630,000 shares $77.81 million +4.3%19.4%17.6 $7.32 3/31/202410,190,000 shares $80.91 million +14.8%19.4%14.6 $7.94 3/15/20248,880,000 shares $80.19 million +0.1%16.9%13.4 $9.03 2/29/20248,870,000 shares $98.72 million -7.4%17.7%14.4 $11.13 Get the Latest News and Ratings for TNGX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Tango Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 2/15/20249,580,000 shares $113.24 million -8.9%19.1%15.1 $11.82 1/31/202410,510,000 shares $123.49 million +0.6%20.6%16.2 $11.75 1/15/202410,450,000 shares $114.32 million +2.7%20.5%14.9 $10.94 12/31/202310,180,000 shares $100.78 million +8.2%19.9%9.9 $9.90 12/15/20239,410,000 shares $100.12 million -3.6%18.4%8.3 $10.64 11/30/20239,760,000 shares $74.18 million +4.5%19.2%7.9 $7.60 11/15/20239,340,000 shares $67.57 million +10.7%18.4%7.7 $7.24 10/31/20238,440,000 shares $70.90 million +23.0%16.1%3.3 $8.40 10/15/20236,860,000 shares $52.75 million +29.4%13.0%2.8 $7.69 9/30/20235,300,000 shares $59.68 million +49.7%11.4%2.6 $11.26 9/15/20233,540,000 shares $30.13 million +37.2%7.6%2 $8.51 8/31/20232,580,000 shares $16.74 million -7.9%5.6%1.6 $6.49 8/15/20232,800,000 shares $19.32 million +71.8%6.9%1.7 $6.90 7/31/20231,630,000 shares $5.51 million +8.7%3.8%1.2 $3.38 7/15/20231,500,000 shares $5.15 million -1.3%3.5%7.8 $3.43 6/30/20231,520,000 shares $5.05 million +1.3%3.5%7.3 $3.32 6/15/20231,500,000 shares $5.42 million -18.5%3.5%6.6 $3.61 5/31/20231,840,000 shares $4.97 million +1.1%3.6%8.2 $2.70 5/15/20231,820,000 shares $6.86 million -18.0%3.6%11 $3.77 4/30/20232,220,000 shares $7.55 million -11.9%4.4%11 $3.40 4/15/20232,520,000 shares $10.74 million -2.0%5.0%12 $4.26 3/31/20232,570,000 shares $10.15 million +9.4%5.1%12.8 $3.95 3/15/20232,350,000 shares $10.06 million +2.2%4.7%12.3 $4.28 2/28/20232,300,000 shares $12.03 million +8.0%4.6%11 $5.23 2/15/20232,130,000 shares $12.10 million +43.9%4.2%9.6 $5.68 1/31/20231,480,000 shares $9.77 million +3.5%2.9%7.2 $6.60 1/15/20231,430,000 shares $11.53 million -2.1%2.9%7.1 $8.06 12/30/20221,460,000 shares $10.59 million +33.9%2.9%6.8 $7.25 12/15/20221,090,000 shares $8.63 million -14.8%2.2%5.1 $7.92 11/30/20221,280,000 shares $9.61 million -0.8%2.8%5.8 $7.51 11/15/20221,290,000 shares $10.45 million +3.2%2.9%6.1 $8.10 10/31/20221,250,000 shares $10.05 million +13.6%2.8%6.2 $8.04 10/15/20221,100,000 shares $5.69 million +3.8%2.4%5.1 $5.17 9/30/20221,060,000 shares $3.84 million -24.3%2.4%4.8 $3.62After Conviction, More Bad News for Trump (Ad)As a former advisor to the CIA, the Pentagon and the White House… I feel it’s my duty to warn you about this coming election meltdown.Click here to see the details because this coming election meltdown could trigger… 9/15/20221,400,000 shares $5.01 million +7.7%3.1%4 $3.58 8/31/20221,300,000 shares $5.33 million -4.4%2.9%3.7 $4.10 8/15/20221,360,000 shares $7.33 million -16.1%3.0%3.4 $5.39 7/31/20221,620,000 shares $6.63 million -3.0%3.6%4 $4.09 7/15/20221,670,000 shares $7.53 million -8.7%3.7%4.2 $4.51 6/30/20221,830,000 shares $8.29 million +81.2%4.1%4.9 $4.53 6/15/20221,010,000 shares $4.13 million +3.8%2.2%2.6 $4.09 5/31/2022973,300 shares $6.51 million -14.6%2.2%3.2 $6.69 5/15/20221,140,000 shares $5.78 million -63.2%2.5%4.3 $5.07 4/30/20223,100,000 shares $22.82 million +3.0%6.9%12.6 $7.36 4/15/20223,010,000 shares $23.00 million -2.9%6.7%13 $7.64 3/31/20223,100,000 shares $23.50 million +40.3%6.9%13.9 $7.58 3/15/20222,210,000 shares $19.51 million +5.2%4.9%11.3 $8.83 2/28/20222,100,000 shares $19.24 million No Change4.7%15.3 $9.16 2/15/20222,100,000 shares $19.64 million No Change5.3%15 $9.35 1/31/20222,100,000 shares $17.91 million +1.9%5.3%12.9 $8.53 1/15/20222,060,000 shares $17.80 million -10.4%5.2%12.4 $8.64 12/31/20212,300,000 shares $25.16 million -2.1%5.8%15.3 $10.94 12/15/20212,350,000 shares $25.76 million -6.4%5.9%14.9 $10.96 11/30/20212,510,000 shares $26.03 million +16.2%6.3%11 $10.37 11/15/20212,160,000 shares $29.16 million +64.9%5.4%9.5 $13.50 10/29/20211,310,000 shares $16.82 million -7.1%3.7%6.4 $12.84 10/15/20211,410,000 shares $19.78 million -6.6%4.0%7.3 $14.03 9/30/20211,510,000 shares $19.52 million +365.6%4.3%7.9 $12.93 9/15/2021324,300 shares $5.13 million +593.0%0.9%1.9 $15.83 8/31/202146,800 shares $542,412.00 +4.2%0.1%0.6 $11.59 8/13/202144,900 shares $0.00 No Change0.1%1.1 $0.00 TNGX Short Interest - Frequently Asked Questions What is Tango Therapeutics' current short interest? Short interest is the volume of Tango Therapeutics shares that have been sold short but have not yet been closed out or covered. As of May 15th, traders have sold 10,620,000 shares of TNGX short. 12.06% of Tango Therapeutics' shares are currently sold short. Learn More on Tango Therapeutics' current short interest. What is a good short interest ratio for Tango Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. TNGX shares currently have a short interest ratio of 18.0. Learn More on Tango Therapeutics's short interest ratio. What is a good short interest percentage for Tango Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 12.06% of Tango Therapeutics' floating shares are currently sold short. Is Tango Therapeutics' short interest increasing or decreasing? Tango Therapeutics saw a decline in short interest during the month of May. As of May 15th, there was short interest totaling 10,620,000 shares, a decline of 2.5% from the previous total of 10,890,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Tango Therapeutics' float size? Tango Therapeutics currently has issued a total of 106,850,000 shares. Some of Tango Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Tango Therapeutics currently has a public float of 88,030,000 shares. How does Tango Therapeutics' short interest compare to its competitors? 12.06% of Tango Therapeutics' shares are currently sold short. Here is how the short interest of companies compare to Tango Therapeutics: Ouster, Inc. (16.26%), CompoSecure, Inc. (32.91%), DocGo Inc. (9.74%), Quantum-Si incorporated (7.26%), Porch Group, Inc. (10.16%), Origin Materials, Inc. (9.54%), Eos Energy Enterprises, Inc. (24.44%), Momentus Inc. (1.09%), Amicus Therapeutics, Inc. (9.76%), Merus (5.93%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.81 billion), Charter Communications, Inc. ($3.30 billion), Occidental Petroleum Co. ($3.10 billion), General Motors ($2.84 billion), Moderna, Inc. ($2.77 billion), AppLovin Co. ($2.22 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.16 billion), Tractor Supply ($2.12 billion), and Williams-Sonoma, Inc. ($2.12 billion). View all of the most shorted stocks. What does it mean to sell short Tango Therapeutics stock? Short selling TNGX is an investing strategy that aims to generate trading profit from Tango Therapeutics as its price is falling. TNGX shares are trading down $0.30 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Tango Therapeutics? A short squeeze for Tango Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of TNGX, which in turn drives the price of the stock up even further. How often is Tango Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including TNGX, twice per month. The most recent reporting period available is May, 15 2024. More Short Interest Resources from MarketBeat Related Companies: OUST Short Interest CMPO Short Interest DCGO Short Interest QSI Short Interest PRCH Short Interest ORGN Short Interest EOSE Short Interest MNTS Short Interest FOLD Short Interest MRUS Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:TNGX) was last updated on 6/8/2024 by MarketBeat.com Staff From Our PartnersSecret energy grid to power millions of homesThis high-security, secret U.S. facility has 2,100 engineers, machinists, and technicians building a new type ...Porter & Company | SponsoredBreaking - The US Gov. Seized CITGODo you want an investment that can double or triple your money in the next three months? The US Court is cu...Augury Research | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredAI Hell Will Break Loose [June 30, 2024] …On June 30, 2024, AI will reach a critical tipping point… Whatever you do, make sure you prepare before Ju...Banyan Hill Publishing | SponsoredWas the Great Financial Crisis fun?The Great Financial Crisis, which actually started in the summer of 2007 and did not end until March of 2009, ...Brooks Enterprises | SponsoredCollapse of the Petrodollar The death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Ru...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tango Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Tango Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.